FLT3 mutations: biology and treatment.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2006, Pages 178-184

  Small, Donald ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ACUTE DISEASE; DRUG ANTAGONISM; GENETICS; HUMAN; MUTATION; MYELOID LEUKEMIA; PATHOLOGY; REVIEW;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOID; MUTATION; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 34147147730     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2006.1.178     Document Type: Review

References (43)